KOS

Pharmaceutical preparations for the treatment of artheriosclerotic diseases, autoimmune diseases, cancer, cardiovascular diseases, central nervous system diseases and disorders, cerebrovascular diseases, diabetes and othe rmetabolic disorders, inflammation and inflammatory diseases, respiratory and infectious diseases, peripheral and central vascular diseases, seizure disorders, shock and central nervous system trauma, stroke, and viral diseases